191 related articles for article (PubMed ID: 33859115)
1. Spinal epidural hematoma in a child with hemophilia A with high titer inhibitors and follow-up with prophylactic emicizumab: case report and literature review.
Villarreal-Martínez L; Sepúlveda-Orozco MDC; García-Viera DA; Robles-Sáenz DA; Bautista-Gómez AJ; Ortiz-Castillo M; González-Martínez G; Mares-Gil JE
Blood Coagul Fibrinolysis; 2021 Sep; 32(6):418-422. PubMed ID: 33859115
[TBL] [Abstract][Full Text] [Related]
2. Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Oldenburg J; Mahlangu JN; Kim B; Schmitt C; Callaghan MU; Young G; Santagostino E; Kruse-Jarres R; Negrier C; Kessler C; Valente N; Asikanius E; Levy GG; Windyga J; Shima M
N Engl J Med; 2017 Aug; 377(9):809-818. PubMed ID: 28691557
[TBL] [Abstract][Full Text] [Related]
3. Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program.
Levy GG; Asikanius E; Kuebler P; Benchikh El Fegoun S; Esbjerg S; Seremetis S
J Thromb Haemost; 2019 Sep; 17(9):1470-1477. PubMed ID: 31124272
[TBL] [Abstract][Full Text] [Related]
4. Life-Threatening Tongue and Retropharyngeal Hemorrhage in a Patient with Hemophilia A with Inhibitors.
Kageyama Y; Matsumoto T; Tawara I; Wada H; Katayama N
Am J Case Rep; 2019 Jul; 20():1022-1026. PubMed ID: 31303639
[TBL] [Abstract][Full Text] [Related]
5. ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.
Gundabolu K; Goldsweig A; Bhatt VR; Koepsell SA; Harper JL
Haemophilia; 2020 Jan; 26(1):e5-e8. PubMed ID: 31694063
[No Abstract] [Full Text] [Related]
6. Prophylactic treatment in hemophilic patients with inhibitors.
Haya S
Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S14-S18. PubMed ID: 31517711
[TBL] [Abstract][Full Text] [Related]
7. Emicizumab for the treatment of haemophilia A: a narrative review.
Franchini M; Marano G; Pati I; Candura F; Profili S; Veropalumbo E; Masiello F; Catalano L; Piccinini V; Vaglio S; Pupella S; Liumbruno GM
Blood Transfus; 2019 May; 17(3):223-228. PubMed ID: 31246563
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report.
Albattat S; Alabdultaif A; Albattat F; Albattat B
J Med Case Rep; 2023 Feb; 17(1):63. PubMed ID: 36814352
[TBL] [Abstract][Full Text] [Related]
9. Conservative therapy for spinal epidural hematoma in a child with hemophilia A with high-titer VIII inhibitors.
Wang G; Wang S
J Int Med Res; 2021 Feb; 49(2):300060520979217. PubMed ID: 33550895
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.
Shima M; Hanabusa H; Taki M; Matsushita T; Sato T; Fukutake K; Fukazawa N; Yoneyama K; Yoshida H; Nogami K
N Engl J Med; 2016 May; 374(21):2044-53. PubMed ID: 27223146
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
Young G; Liesner R; Chang T; Sidonio R; Oldenburg J; Jiménez-Yuste V; Mahlangu J; Kruse-Jarres R; Wang M; Uguen M; Doral MY; Wright LY; Schmitt C; Levy GG; Shima M; Mancuso ME
Blood; 2019 Dec; 134(24):2127-2138. PubMed ID: 31697801
[TBL] [Abstract][Full Text] [Related]
12. Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors-a single-center cohort.
Barg AA; Avishai E; Budnik I; Levy-Mendelovich S; Barazani TB; Kenet G; Livnat T
Pediatr Blood Cancer; 2019 Nov; 66(11):e27886. PubMed ID: 31348595
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough Bleeding Episodes at Minimum and Improvement in Quality of Life in a Child with Severe Hemophilia A with Inhibitors Treated with Emicizumab: A Case Report from Chile.
Abarca-Villaseca V; Soto-Arellano V
Am J Case Rep; 2021 Apr; 22():e929598. PubMed ID: 33883542
[TBL] [Abstract][Full Text] [Related]
14. Safety first: Tracking adverse events associated with new therapies for people with hemophilia.
Recht M
J Thromb Haemost; 2021 Jan; 19 Suppl 1():3-5. PubMed ID: 33331044
[No Abstract] [Full Text] [Related]
15. Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.
McCary I; Guelcher C; Kuhn J; Butler R; Massey G; Guerrera MF; Ballester L; Raffini L
Haemophilia; 2020 Jul; 26(4):631-636. PubMed ID: 32311809
[TBL] [Abstract][Full Text] [Related]
16. Emicizumab in pediatric hemophilia: Bleeding and surgical outcomes from a single-center retrospective study.
Cohen CT; Diaz R
Pediatr Blood Cancer; 2021 Nov; 68(11):e29325. PubMed ID: 34490988
[TBL] [Abstract][Full Text] [Related]
17. [Spontaneous disappearance of the inhibitor during emicizumab therapy in a patient with mild hemophilia A].
Matsumoto A; Ogawa Y; Uchiyama Y; Ishikawa T; Naito C; Kobayashi N; Miyazawa Y; Ishizaki T; Inoue M; Moteki Y; Kitazawa S; Murakami M; Matsumoto N; Handa H
Rinsho Ketsueki; 2022; 63(10):1392-1396. PubMed ID: 36351645
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Emicizumab in Acquired Factor VIII Deficiency.
Hess KJ; Patel P; Joshi AM; Kotkiewicz A
Am J Case Rep; 2020 May; 21():e922326. PubMed ID: 32376817
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment by switching from activated prothrombin complex concentrate to emicizumab therapy in a hemophilia A patient with inhibitors].
Sakamoto A; Nakadate H; Watanabe N; Ishiguro A
Rinsho Ketsueki; 2020; 61(6):617-620. PubMed ID: 32624534
[TBL] [Abstract][Full Text] [Related]
20. Torticollis in a haemophilic infant with inhibitor: a case of spinal epidural haematoma.
Oymak Y; Muminoglu N; Ay Y; Karapinar TH; Köker SA; Töret E; Ylmaz AK; Gürçnar M; Vergin C
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):576-9. PubMed ID: 26650462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
